title: Cerebrotendinous xanthomatosis: the effectiveness of high-dose piracetam for the treatment of cerebellar and sensorial ataxia.
authors.affiliation: Department of Neurology, Cerrahpasa School of Medicine, Istanbul University, K.M. Pasa, 34098, Istanbul, Turkey.
authors.forename: Ugur
authors.initials: U
authors.lastname: Uygunoglu
authors.forename: Aysegul
authors.initials: A
authors.lastname: Gunduz
authors.forename: Sukriye F
authors.initials: SF
authors.lastname: Menku
authors.forename: Basak
authors.initials: B
authors.lastname: Yilmaz
authors.forename: Esra
authors.initials: E
authors.lastname: Hatipoglu
authors.forename: Cengiz
authors.initials: C
authors.lastname: Yalcinkaya
authors.forename: Sabahattin
authors.initials: S
authors.lastname: Saip
authors.forename: Hulya
authors.initials: H
authors.lastname: Apaydin
mesh_terms: D000328:Adult; D000842:Ankle / Q000473:pathology; D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use*; D001921:Brain / Q000473:pathology; D002524:Cerebellar Ataxia / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D002574:Cervical Vertebrae; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D010889:Piracetam / Q000627:therapeutic use*; D013116:Spinal Cord / Q000473:pathology; D019294:Xanthomatosis, Cerebrotendinous / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology
chemical_list: D018726:Anti-Dyskinesia Agents; D010889:Piracetam
references.citation: Neurochem Res. 2013 Aug;38(8):1704-14
references.pmid: 23677777
references.citation: Clin Neurosci. 1995-1996;3(4):253-7
references.pmid: 8891399
references.citation: Clin Neuropharmacol. 2009 Jan-Feb;32(1):53-4
references.pmid: 19471185
references.citation: Radiology. 2000 Dec;217(3):869-76
references.pmid: 11110956
references.citation: N Engl J Med. 1987 May 14;316(20):1233-8
references.pmid: 3106810
references.citation: Drugs. 2010 Feb 12;70(3):287-312
references.pmid: 20166767
references.citation: Mov Disord. 2006 Jan;21(1):116-8
references.pmid: 16149096
references.citation: J Clin Pharm Ther. 2008 Apr;33(2):175-8
references.pmid: 18315783
references.citation: Mov Disord. 2003 Apr;18(4):457-9
references.pmid: 12671958
references.citation: CNS Drug Rev. 2005 Summer;11(2):169-82
references.pmid: 16007238
references.citation: Mov Disord. 2013 Sep;28(10):1465
references.pmid: 23495097
references.citation: Neuroradiology. 2012 Jun;54(6):649-51
references.pmid: 22415344
references.citation: Clin Invest Med. 2004 Feb;27(1):42-50
references.pmid: 15061585
references.citation: J Biol Chem. 1991 Apr 25;266(12):7779-83
references.pmid: 2019602
references.citation: N Engl J Med. 1984 Dec 27;311(26):1649-52
references.pmid: 6504105
references.citation: Metabolism. 1999 Feb;48(2):233-8
references.pmid: 10024088